BCAB
BioAtla (BCAB)
NASDAQ
$3.99+$0.08 (+2.05%)
Price as of Jul 14, 2026 4:02 PM EDT
  • $6.5M
    Market Cap
  • -80.40%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
BCAB
vs History
vs S&P 500
Profitability
-1
Growth
N/A
Low Earnings Volatility
0

Momentum Score

Score: 68
Valuation
BCAB
vs History
vs S&P 500
3-Month Momentum
-17.79%
12-Month Momentum
-80.96%
3-Month Risk Adjusted Momentum
-40.78%
12-Month Risk Adjusted Momentum
-61.21%

True Yield

N/A
No data found

No data found

Financial Health Score

N/A
Valuation
BCAB
vs History
vs S&P 500
Ohlson's O-Score
1